Cinclus Pharma Holding publ AB
STO:CINPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cinclus Pharma Holding publ AB
STO:CINPHA
|
SE |
|
E
|
Element 25 Ltd
SWB:QFP
|
AU |
|
Repsol SA
F:REPA
|
ES |
Bankruptcy Probability
Cinclus Pharma Holding publ AB's probability of bankruptcy is 3.3%, pointing to a small but noticeable default risk. The solvency score is 49/100 — a warning sign of potential financial weakness.
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cinclus Pharma Holding publ AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
C
|
Cinclus Pharma Holding publ AB
STO:CINPHA
|
546m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IN |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
4.5T INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
S
|
Sandoz Group AG
SIX:SDZ
|
32.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
19.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
88.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
62.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
Croda International PLC
LSE:CRDA
|
4.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Balchem Corp
NASDAQ:BCPC
|
5.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vireo Growth Inc
OTC:VREOF
|
5.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
C
|
Changchun High & New Technology Industries Group Inc
SZSE:000661
|
33.3B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
CTI Biopharma Corp
F:CEPS
|
3.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cinclus Pharma Holding publ AB's probability of bankruptcy is 3.3%, pointing to a small but noticeable default risk.
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cinclus Pharma Holding publ AB has total debt of 49.8m . This includes both short-term (45.8m ) and long-term (4m ) debt.
You can find a full breakdown on its Balance Sheet.
